The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
White Papers
The white paper written as a result of the AHRMM Executive Thought Leader Summit held during the AHRMM14 Annual Conference & Exhibition in Or
White Papers
The paper presents healthcare supply chain tools and strategies for navigating the Cost, Quality, and Outcomes (CQO) Movement, and explores new ini
White Papers
This paper addresses the importance of the supply chain on overall health care costs and how transparent data can lead to a best practice sup
Case Studies
AHRMM is offering a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
Case Studies
AHRMM is developing a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
Case Studies
The following leading practice describes methods used to reduce Hospital Acquired Pressure Ulcers (HAPU).